Cardiac Rhythm Management Market Projected to Gain Significant Value through 2032

Posted by Ganesh Shinde on January 24th, 2023

The global cardiac rhythm management market is expected to grow at a CAGR of 4% from US$ 22.1 billion in 2021 to US$ 26.8 billion in 2025.

The increase in demand for cardiac rhythm management devices and the cardiac rhythm management market as a whole is primarily due to technological advancements. A number of well-known cardiac equipment suppliers are now utilising augmented reality (AR) and virtual reality for staff training (VR).

The increased use of information technology in healthcare provides opportunities to prevent the closure of cardiac rhythm management sales during medical emergencies.

Sales of cardiac rhythm management devices are expected to be hampered by a lack of awareness about sudden cardiac arrests and the high cost of the devices. As disposable income rises, so will the number of ageing people; technological advancement will drive up demand for cardiac rhythm management.

According to research published in 2017 by the US Centers for Disease Control and Prevention (CDC), atrial fibrillation is responsible for more than 75,000 hospitalisations. It's also worth noting that atrial fibrillation affects a sizable proportion of the US population. As a result, it is expected to rise even further in the forecast period.

Key Players

The writer will create content on the general strategies of market players. And then will write the key players in the market are: Medtronic Plc, St. Jude Medical Inc, Boston Scientific Corporation, Abbott Laboratories, Biotronik, and Sorin Group.

Read More@ https://www.futuremarketinsights.com/reports/cardiac-rhythm-management-market

Segmentation

The report provides insights on the important highlights and current trends prevailing in the market. This helps the readers to gain a deeper understanding and form an unbiased opinion on the market.

Numerous segmentations have been provided for this market based on:

On the basis of devices, cardiac rhythm management market is broadly segmented as:

  • Cardiac Rhythm Pacemakers
  • Single Chamber Pacemakers
  • Dual Chamber Pacemakers
  • Cardiac Resynchronization Therapy
  • Cardiac Resynchronization Therapy – Pacemakers
  • Cardiac Resynchronization Therapy – Defibrillators
  • Implantable Cardioverter Defibrillators
  • Transvenous implantable cardioverter defibrillators (T-ICDs)
  • Subcutaneous implantable cardioverter defibrillators (S-ICDs)
  • Implantable Loop Recorder 

Like it? Share it!


Ganesh Shinde

About the Author

Ganesh Shinde
Joined: October 27th, 2022
Articles Posted: 363

More by this author